Lyman, Gary;
Carrier, Marc;
Ay, Cihan;
Nisio, Marcello;
Hicks, Lisa;
Khorana, Alok;
Leavitt, Andrew;
Lee, Agnes;
Macbeth, Fergus;
Morgan, Rebecca;
Noble, Simon;
Sexton, Elizabeth;
Stenehjem, David;
Wiercoioch, Wojtek;
Kahale, Lara;
Alonso-Coello, Pablo.
Venous thromboembolism (VTE) is a common complication among patients with cancer. Patients with cancer and VTE are at a markedly increased risk for morbidity and mortality. These evidence-based guidelines of the American Society of Hematology (ASH) are intended to support patients, clinicians, and other ...
Macle, L;
Cairns, J;
Leblanc, K;
Tsang, T;
Skanes, A;
Cox, JL;
Healey, JS;
Bell, A;
Pilote, L;
Andrade, JG;
Mitchell, LB;
Atzema, C;
Gladstone, D;
Sharma, M;
Verma, S;
Connolly, S;
Dorian, P;
Parkash, R;
Talajic, M;
Nattel, S;
Verma, A.
The Canadian Cardiovascular Society (CCS) Atrial Fibrillation (AF) Guidelines Committee provides periodic reviews of new data to produce focused updates that address clinically important advances in AF management. This 2016 Focused Update deals with: (1) the management of antithrombotic therapy for AF pa...
Anticoagulants,
Cardiotoniques,
Antiagrégants plaquettaires,
Digoxine,
Magnésium,
Syndrome coronarien aigu/thérapie,
Algorithmes,
Anticoagulants/usage thérapeutique,
Auricule de l'atrium/chirurgie,
Fibrillation auriculaire,
Entraînement électrosystolique,
Cardiotoniques/effets indésirables,
Ablation par cathéter,
Cardiotoniques/administration et posologie,
Fibrillation auriculaire/thérapie,
Fibrillation auriculaire/complications,
Hémorragie/induit chimiquement,
Hémorragie/prévention et contrôle,
Magnésium/usage thérapeutique,
Intervention coronarienne percutanée,
Antiagrégants plaquettaires/usage thérapeutique,
Complications postopératoires/prévention et contrôle,
Infarctus du myocarde avec sus-décalage du segment ST/thérapie,
Accident vasculaire cérébral/prévention et contrôle,
Maladie des artères coronaires/complications,
Digoxine/administration et posologie,
Digoxine/effets indésirables,
Association de médicaments,
Inhibiteurs du facteur Xa/usage thérapeutique,
Fibrinolytiques/usage thérapeutique,
Inhibiteurs du facteur Xa
Disminuir la heterogeneidad de la atención pre e intrahospitalaria del TCE severo en Colombia para generar una práctica basada en evidencia científica. Establecer criterios para la referencia yel traslado de pacientes adultos con TCE dentro de un sistema de atención en trauma. Promover una eficienci...
Chest; 141 (2,supl), 2012
The Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines differs substantially from the prior versions both in process and in content. In this introduction, we describe some of the differences and the rationale for t...
Guyatt, G. H;
Norris, S. L;
Schulman, S;
Hirsh, J;
Eckman, M. H;
Akl, E. A;
Crowther, M;
Vandvik, P. O;
Eikelboom, J. W;
McDonagh, M. S;
Lewis, S. Z;
Gutterman, D. D;
Cook, D. J;
Schünemann, H. J.
Chest; 141 (2,supl), 2012
BACKGROUND: To develop the Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: ACCP Evidence-Based Clinical Practice Guidelines (AT9), the American College of Chest Physicians (ACCP) assembled a panel of clinical experts, information scientists, decision scientists, and systematic review and gui...
Since publication of the seventh American College of Chest Physicians (ACCP) supplement on antithrombotic and thrombolytic therapy, the results of clinical trials have provided important new information on the management of thromboembolic disorders, and the science of developing recommendations has advan...
